Myriam Moalla (Moalla Myriam)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis Patients

Dna Methylation

Ejection Fraction

Disease Activity

Top Venues

British journal of clinical pharmacology

Clinical case reports

Drug metabolism and personalized therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Mahmoud Ines, Myriam Moalla, Ben Tekaya Aicha, Bouden Selma, Rouached Leila, Tekaya Rawdha, Saidane Olfa, Gorji Yousr, Elleuch Mohamed, Laatar Ahmed, Hamdi Wafa, Abdelmoula Leila, Sfar Imen
Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients. Drug metabolism and personalized therapy (2023)
Ines Mahmoud, Myriam Moalla, Aicha Ben Tekaya, Rim Charfi, Leila Rouached, Selma Bouden, Rawdha Tekaya, Olfa Saidane, Leila Abdelmoula, Imen Sfar
Assessment of the influence of Fc-γ receptor polymorphisms on biologics' pharmacokinetics in Tunisian rheumatoid arthritis patients. British journal of clinical pharmacology (2023)
Mahmoud Ines, Myriam Moalla, Ben Tekaya Aicha, Charfi Rim, Rouached Leila, Bouden Selma, Tekaya Rawdha, Saidane Olfa, Abdelmoula Leila, Sfar Imen
Assessment of the influence of Fc gamma receptors polymorphisms on biologics' pharmacokinetics in Tunisian rheumatoid arthritis patients. British journal of clinical pharmacology (2023)
Lassoued Ferjani Hanene, Myriam Moalla, Kaouther Maatallah, Dorra Ben Nessib, Wafa Triki, Dhia Kaffel, Wafa Hamdi
Intra-articular hip neurofibromas in von Recklinghausen's disease. Clinical case reports 9 (9) (2021)